Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-06

Clinical Trial Update: Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders [Phase 1]

View source ↗

Summary

Completed Phase 1 pilot study evaluating total body irradiation with cyclophosphamide, anti-thymocyte globulin, and autologous CD34-selected peripheral blood st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOPHOSPHAMIDE (Cyclophosphamide)
  • Thymoglobulin (rabbit anti-thymocyte globulin)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Systemic Sclerosis, Systemic Lupus Erythematosus | Phase 1 | Status: COMPLETED